Meeting the needs of patients, providers, and payers will be key to overcoming the limitations of current point-of-care (POC) testing methods, according to keynote speaker Timothy Still, CEO of Sense Biodetection, on the opening day of the Next Generation Dx Summit in Washington, D.C. Many of the ... Read More
|
Secondary bacterial and fungal infections have threatened hospitalized patients for decades and become more urgent as pathogens develop resistance to common antibiotics. Recently, the Centers for Disease Control and Prevention confirmed what many frontline workers and epidemiologists already ... Read More
|
Attention COVID-19 research community: the Mayo Clinic has made a discovery that could help explain why some people who get infected with the SARS-CoV-2 virus suffer badly while others feel only mildly ill. The hypothesis to be tested is whether an increase in protein expression controlled by ACE2 ... Read More
|